European Master's Programme in Biomedical Engineering
an
EIT-label Entrepreneurship Master's programme
SORRY WE NO LONGER HAVE A STUDENT INTAKE
(application is no longer possible)
CEMACUBE will be discontinued per September 2022
CEMACUBE is a European double degree Master's programme in Biomedical Engineering, running at the Universities of Groningen, Ghent, Dublin, Aachen and Prague (see Participating universities).
CEMACUBE has the prestigious EIT-label.
Are you a bachelor student with an interest in the medical field and in Engineering?
And are you in possession of a Bachelor's Degree in Biomedical, chemical, electronical or mechanical engineering or applied science before 1 September 2020? The Biomedical Engineering Master's programme might be very interesting for you! Please read more about the Selection Criteria. or go to Apply now!
Are you looking for a versatile Master's Course?
Among others the following course elements will be discussed in the first two semesters of the study: Anatomy and Histology, Biochemistry, Methodical Design, Tissue Engineering, Biomechanics, Biomaterials etc.
Please read more about the set-up of CEMACUBE here: Programme Structure.
Do you want to be able to choose from a diverse range of European cities to study at their Universities?
In this master's course you can switch up to three times between different countries and cities. The first three semesters you can follow in Aachen (Germany), Dublin (Ireland), Ghent (Belgium), Groningen (The Netherlands) and Prague (Czech Republic). Please read more about the specializations of the universities.
Would you like to have a chat with current CEMACUBE students?
Please click here to visit our Facebook page for prospective students! Here you can ask the students about their experiences and other study or visa related questions... anything you like.
If you still have questions after visiting our website, please contact our CEMACUBE manager coordinator, This email address is being protected from spambots. You need JavaScript enabled to view it..